Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0005929 | cilium | 4 | 1 |
GO:0005930 | axoneme | 2 | 1 |
GO:0042995 | cell projection | 2 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
GO:0120025 | plasma membrane bounded cell projection | 3 | 1 |
Related structures:
AlphaFold database: E9ATU5
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 111 | 115 | PF00656 | 0.496 |
CLV_C14_Caspase3-7 | 24 | 28 | PF00656 | 0.424 |
CLV_C14_Caspase3-7 | 249 | 253 | PF00656 | 0.601 |
CLV_NRD_NRD_1 | 260 | 262 | PF00675 | 0.669 |
CLV_PCSK_KEX2_1 | 260 | 262 | PF00082 | 0.696 |
CLV_PCSK_KEX2_1 | 35 | 37 | PF00082 | 0.419 |
CLV_PCSK_KEX2_1 | 61 | 63 | PF00082 | 0.369 |
CLV_PCSK_PC1ET2_1 | 35 | 37 | PF00082 | 0.419 |
CLV_PCSK_PC1ET2_1 | 61 | 63 | PF00082 | 0.369 |
CLV_PCSK_SKI1_1 | 107 | 111 | PF00082 | 0.588 |
CLV_PCSK_SKI1_1 | 78 | 82 | PF00082 | 0.408 |
DEG_Nend_UBRbox_2 | 1 | 3 | PF02207 | 0.686 |
DOC_CKS1_1 | 201 | 206 | PF01111 | 0.580 |
DOC_MAPK_gen_1 | 60 | 69 | PF00069 | 0.432 |
DOC_MAPK_MEF2A_6 | 60 | 69 | PF00069 | 0.444 |
DOC_MAPK_NFAT4_5 | 62 | 70 | PF00069 | 0.444 |
DOC_SPAK_OSR1_1 | 138 | 142 | PF12202 | 0.369 |
DOC_USP7_UBL2_3 | 103 | 107 | PF12436 | 0.444 |
DOC_WW_Pin1_4 | 200 | 205 | PF00397 | 0.524 |
LIG_14-3-3_CanoR_1 | 158 | 168 | PF00244 | 0.444 |
LIG_14-3-3_CanoR_1 | 181 | 189 | PF00244 | 0.370 |
LIG_14-3-3_CanoR_1 | 191 | 197 | PF00244 | 0.433 |
LIG_14-3-3_CanoR_1 | 244 | 250 | PF00244 | 0.597 |
LIG_BRCT_BRCA1_1 | 184 | 188 | PF00533 | 0.401 |
LIG_FHA_1 | 161 | 167 | PF00498 | 0.394 |
LIG_FHA_2 | 201 | 207 | PF00498 | 0.568 |
LIG_FHA_2 | 22 | 28 | PF00498 | 0.424 |
LIG_LIR_Apic_2 | 203 | 208 | PF02991 | 0.495 |
LIG_LIR_Gen_1 | 124 | 134 | PF02991 | 0.373 |
LIG_LIR_Nem_3 | 124 | 130 | PF02991 | 0.349 |
LIG_Pex14_1 | 184 | 188 | PF04695 | 0.344 |
LIG_Pex14_2 | 100 | 104 | PF04695 | 0.369 |
LIG_PTAP_UEV_1 | 214 | 219 | PF05743 | 0.587 |
LIG_SH2_CRK | 205 | 209 | PF00017 | 0.526 |
LIG_SH2_NCK_1 | 205 | 209 | PF00017 | 0.526 |
LIG_SH2_PTP2 | 127 | 130 | PF00017 | 0.408 |
LIG_SH2_SRC | 205 | 208 | PF00017 | 0.503 |
LIG_SH2_STAT3 | 30 | 33 | PF00017 | 0.344 |
LIG_SH2_STAT5 | 127 | 130 | PF00017 | 0.429 |
LIG_SH2_STAT5 | 155 | 158 | PF00017 | 0.328 |
LIG_SH3_2 | 215 | 220 | PF14604 | 0.712 |
LIG_SH3_3 | 198 | 204 | PF00018 | 0.477 |
LIG_SH3_3 | 212 | 218 | PF00018 | 0.557 |
LIG_SH3_3 | 92 | 98 | PF00018 | 0.321 |
LIG_SUMO_SIM_par_1 | 162 | 167 | PF11976 | 0.401 |
LIG_SUMO_SIM_par_1 | 93 | 99 | PF11976 | 0.346 |
LIG_TYR_ITIM | 125 | 130 | PF00017 | 0.369 |
MOD_CK1_1 | 126 | 132 | PF00069 | 0.397 |
MOD_CK1_1 | 162 | 168 | PF00069 | 0.485 |
MOD_CK1_1 | 243 | 249 | PF00069 | 0.661 |
MOD_CK1_1 | 5 | 11 | PF00069 | 0.599 |
MOD_CK2_1 | 145 | 151 | PF00069 | 0.359 |
MOD_CK2_1 | 243 | 249 | PF00069 | 0.628 |
MOD_GlcNHglycan | 246 | 249 | PF01048 | 0.653 |
MOD_GlcNHglycan | 62 | 65 | PF01048 | 0.444 |
MOD_GlcNHglycan | 7 | 10 | PF01048 | 0.619 |
MOD_GSK3_1 | 1 | 8 | PF00069 | 0.742 |
MOD_GSK3_1 | 117 | 124 | PF00069 | 0.558 |
MOD_GSK3_1 | 129 | 136 | PF00069 | 0.454 |
MOD_GSK3_1 | 240 | 247 | PF00069 | 0.659 |
MOD_GSK3_1 | 255 | 262 | PF00069 | 0.576 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.752 |
MOD_NEK2_1 | 192 | 197 | PF00069 | 0.485 |
MOD_NEK2_1 | 230 | 235 | PF00069 | 0.520 |
MOD_NEK2_1 | 240 | 245 | PF00069 | 0.559 |
MOD_NEK2_1 | 254 | 259 | PF00069 | 0.522 |
MOD_NEK2_1 | 31 | 36 | PF00069 | 0.408 |
MOD_NEK2_1 | 70 | 75 | PF00069 | 0.344 |
MOD_NEK2_1 | 82 | 87 | PF00069 | 0.280 |
MOD_PIKK_1 | 230 | 236 | PF00454 | 0.608 |
MOD_PKA_1 | 60 | 66 | PF00069 | 0.401 |
MOD_PKA_2 | 192 | 198 | PF00069 | 0.389 |
MOD_PKA_2 | 243 | 249 | PF00069 | 0.576 |
MOD_Plk_1 | 176 | 182 | PF00069 | 0.485 |
MOD_Plk_1 | 82 | 88 | PF00069 | 0.443 |
MOD_Plk_4 | 123 | 129 | PF00069 | 0.485 |
MOD_Plk_4 | 235 | 241 | PF00069 | 0.584 |
MOD_ProDKin_1 | 200 | 206 | PF00069 | 0.531 |
MOD_SUMO_rev_2 | 83 | 92 | PF00179 | 0.429 |
TRG_ENDOCYTIC_2 | 127 | 130 | PF00928 | 0.369 |
TRG_ENDOCYTIC_2 | 16 | 19 | PF00928 | 0.422 |
TRG_ER_diArg_1 | 259 | 261 | PF00400 | 0.709 |
TRG_NES_CRM1_1 | 21 | 33 | PF08389 | 0.310 |
TRG_Pf-PMV_PEXEL_1 | 48 | 52 | PF00026 | 0.401 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P360 | Leptomonas seymouri | 79% | 100% |
A0A1X0NFH5 | Trypanosomatidae | 54% | 100% |
A0A3Q8IJR1 | Leishmania donovani | 95% | 100% |
A0A422N6F8 | Trypanosoma rangeli | 55% | 83% |
A4HQ27 | Leishmania braziliensis | 88% | 100% |
A4IDT3 | Leishmania infantum | 95% | 100% |
D0A8U1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 53% | 100% |
Q4Q0Q1 | Leishmania major | 96% | 100% |